South Bow SOBO 深 沪
已收盘 08-01 16:00:00 美东时间
26.35
+0.090
+0.34%
华盛通- 最 高26.41
- 今 开26.31
- 成交量 42.87万股
- 最 低 25.85
- 昨 收 26.26
- 总市值 54.81亿
- 52周最高 27.13
- 市盈率 静 17.34
- 换手率 0.21%
- 52周最低 20.48
- 委 比 0.00%
- 总股本 2.08亿
- 历史最高 26.60
- 量 比 1.03
- 振 幅 2.13%
- 历史最低 20.48
- 每 手 1
- 风险率 1.07%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多South Bow Announces Extension of Expiration Date for Exchange Offers Relating to Certain Outstanding Notes
South Bow Corp. announced the extension of the expiration date for exchange offers relating to certain outstanding notes. The Canadian Exchange Offer for 7.625% and 7.500% Junior Subordinated Notes due 2055, and the U.S. Exchange Offer for Senior Notes due 2027, 2029, 2034, and 2054, have been extended from Aug. 4, 2025, to Aug. 6, 2025. The prospectuses for both offers have been filed with regulatory bodies, and South Bow recommends holders revi...
07-17 21:00
South Bow Announces Timing of Second-quarter 2025 Results and Conference Call and Webcast
South Bow Corp. will release its second-quarter 2025 financial and operational results after markets close on Aug. 6, 2025. A conference call and webcast to discuss the results will be held on Aug. 7, 2025, at 8 a.m. MT (10 a.m. ET). Participants can register in advance to receive a unique PIN for access. The replay will be available on the company’s investor website following the event. Forward-looking statements in this release are subject to r...
07-10 23:42
美股大行评级 | 潜在涨幅300.0%！HC Wainwright & Co.：Armata Pharmaceuticals获机构升目标价至9美元，维持"买入"评级
潜在涨幅300.0%！HC Wainwright & Co.：Armata Pharmaceuticals获机构升目标价至9美元，维持"买入"评级
05-21 16:44
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
RBC Capital Reiterates Outperform on South Bow, Maintains $38 Price Target
RBC Capital analyst Maurice Choy reiterates South Bow (NYSE:SOBO) with a Outperform and maintains $38 price target.
05-20 01:18
Scotiabank Remains a Hold on South Bow Corp (SOBO)
In a report released today, Robert Hope from Scotiabank maintained a Hold ratin...
05-16 19:17
South Bow Corporation declares $0.50 dividend
South Bow Corporation (TSX:SOBO:CA) declares $0.50/share quarterly dividend, in line with previous. Forward yield 5.53% Payable July 15; for shareholders of record June 30; ex-div June 30. See SOBO:CA...
05-16 05:12
South Bow Q1 Adj. EPS $0.47 Beats $0.44 Estimate, Sales $498.00M Miss $527.00M Estimate
South Bow (NYSE:SOBO) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.44 by 6.82 percent. This is a 14.55 percent decrease over earnings of $0.55 per share from the same
05-16 05:11
Earnings Scheduled For May 15, 2025
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is expected t...
05-15 16:32
WESTERN MIDSTREAM ANNOUNCES APPOINTMENT OF ROBERT G. PHILLIPS AS INDEPENDENT DIRECTOR
HOUSTON, May 5, 2025 /PRNewswire/ -- Today Western Midstream Partners, LP (NYSE: WES) ("WES" or the "Partnership") announced that Robert G. (Bob) Phillips has been appointed as an independen...
05-05 19:00
